50% off Premium Yearly

TSE:L
This summary was created by AI, based on 11 opinions in the last 12 months.
Loblaw Companies Ltd, a leading food and drug retailer in Canada, has experienced significant growth, especially following its acquisition of Shoppers Drug Mart. Experts note its strong performance amid food inflation, and the success of its No Frills discount brand has drawn positive attention. However, concerns about overvaluation are prevalent, with many analysts watching for signs of sustainable growth, especially with increasing competition from Walmart and Costco. While some view the company as a solid defensive investment, others are cautious, indicating that current valuations appear stretched compared to historical standards. Analysts provide mixed views on its future performance, recommending investors consider alternatives in the retail space.
Acquiring Shoppers Drug (SC-T) and this will be the biggest market share in Canada at 16%. Shoppers was getting into the food business and they will definitely be supplied by Loblaws and that is one of the attractions. This area is still very competitive and people are getting into each other’s business and that does not appeal to him. Even though this is the biggest, he thinks they will suffer from competitive pressures.
Weston is the parent of Loblaw’s. She prefers the pure plays and L-T is the pure play. They are unlocking the value in their real estate and that is giving a kick to the stock. She is concerned about what Target will do to the landscape and to L-T. She thinks it is a fairly safe company although not going to provide a great return. She would not be opposed to taking a little profit here. We do know Target will be launching this year with aggressive pricing strategies.
Can see 20%-25% upside in the stock. Shoppers acquisition has a lot of potential for them to realize synergies and increase their operating profit. $55-$60 in 12 months. (See Top Picks.)